Patch, HRIPT, and Safety

      An industry standard test for discerning both the immediate irritation and the long term, systemic or allergenic reaction potential of a given topical product or treatment. Useful for supporting claims such as “non-sensitizing, non-irritating, not a primary irritant, dermatologist tested and dermatologist approved.”

• Shared Panel 50, 100, 200 subjects
• 24, 48 or Repeat Insult Patch
• Sensitive Skin Panels
• Dermatologist, Pediatrician, & specialist MD review and sign off

      A simplified, single application irritation test for topically applied products. Does not include a measure of sensitization.

      A skin test used to confirm or rule out the presence of allergic contact dermatitis, often used after initial patch testing for secondary confirmation.

    These tests are designed to ensure that products don’t cause irritation in or around the sensitive eye area.

 Panels can be designed to help support claims such as “ophthalmologically/ophthalmologist tested, safe for use around the sensitive eye area, safe for contact lens wearers, no tears.”

     Patch and safety testing are both important ways to support claims as well as serve as preliminary markers for the irritation and sensitization capacity of a product. Many third party vendors and retailers require safety testing to be completed prior to listing/distributing products, and consumers often recognize products as “safe” based on the patch related claims listed on the product labels.